US to impose 100% tariffs on generic drug imports by August 2028
The US administration announced a phased tariff plan targeting generic pharmaceutical imports, reaching 200% by 2029 to incentivize domestic manufacturing. The policy's efficacy in shifting supply chains versus its potential impact on drug affordability and healthcare costs remains uncertain.
Score Breakdown
Intelligence Tags
Locations
Entities
Part of 2 situations
Brazil-US Trade Friction Amidst Brazilian Industrial Policy Shift
Brazil is actively pursuing a state-led industrial development strategy ('Brasil Soberano 3') and diversifying export markets in response to confirmed US trade restrictions. Concurrently, the Brazilian government is evaluating a formal WTO dispute against the US, signaling potential escalation in bilateral trade relations. The impact of US tariffs is also influencing Brazilian domestic politics, potentially bolstering President Lula's standing.